文献速递主动脉外科

支架植入修复夹层主动脉试验的三年结局

Three-year outcomes of the Dissected Aorta Repair Through Stent Implantation trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-09-11

这项前瞻性、非随机、国际性研究评估Ascyrus Medical Dissection Stent联合标准手术治疗急性DeBakey I型主动脉夹层的临床与影像学结局,共46例纳入分析,中位随访3年。30天和3年总体死亡率分别为13.0%和21.7%,30天新发卒中率为15.2%,3年内无装置取出,主动脉弓及近端降主动脉重构良好。

要点

  • 30天和3年总体死亡率分别为13.0%(6/46)和21.7%(10/46)。
  • 30天新发卒中率为15.2%(7/46),3年内无装置取出。
  • 3年时0、1、2区主动脉总直径减小或稳定的比例分别为91.7%、72.7%、75.0%。

核心结论

  • Ascyrus Medical Dissection Stent用于急性DeBakey I型主动脉夹层治疗,作为一项简单技术可修复主动脉弓和近端降主动脉并促进积极的主动脉重构。
  • 正在进行的Dissected Aorta Repair Through Stent Implantation试验随访将继续提供关于主动脉弓积极重构的长期、前瞻性临床结局和影像学数据。

研究设计与样本

  • 前瞻性、非随机、国际性研究(Dissected Aorta Repair Through Stent Implantation试验),评估Ascyrus Medical Dissection Stent联合急性DeBakey I型主动脉夹层标准手术治疗的临床和影像学结局。
  • 共47例患者接受急诊手术修复并成功植入Ascyrus Medical Dissection Stent,1例因用于医源性夹层被排除分析,最终分析46例。
  • 46例中56.5%(26/46)有术前临床和影像学灌注不良,43.5%(20/46)无术前临床和影像学灌注不良;所有患者原发破口位于升主动脉,97.8%(45/46)接受半弓修复。
  • 中位随访时间为3年。

主要发现

  • 30天总体死亡率为13.0%(6/46),3年总体死亡率为21.7%(10/46)。
  • 30天总体新发卒中率为15.2%(7/46)。
  • 3年中位随访期间任何时间均无装置取出。
  • 3年时0区、1区、2区主动脉总直径减小或稳定的比例分别为91.7%、72.7%、75.0%。
  • 3年时假腔完全或部分血栓形成的比例在0区为90.5%、1区为60.0%、2区为68.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to evaluate the clinical and radiographic outcomes of the Ascyrus Medical Dissection Stent in a prospective, nonrandomized, international study (Dissected Aorta Repair Through Stent Implantation) of patients with acute DeBakey type I aortic dissection. METHODS: The Ascyrus Medical Dissection Stent was used in combination with the standard surgical management of acute DeBakey type I aortic dissection I to treat patients with (56.5%, 26/46) and without (43.5%, 20/46) preoperative clinical and radiographic malperfusion. All patients had a primary entry tear in the ascending aorta, and 97.8% (45/46) were treated with a hemiarch repair. Median follow-up was 3 years. RESULTS: All 47 patients underwent emergency surgical repair with successful Ascyrus Medical Dissection Stent implantation. One patient was excluded from analysis due to use in iatrogenic dissection. Overall mortality at 30 days and 3 years was 13.0% (6/46) and 21.7% (10/46), respectively. Overall new stroke rate at 30 days was 15.2% (7/46). No devices were explanted at any time during the 3-year median follow-up. At 3 years, the total aortic diameter in zones 0, 1, and 2 decreased or remained stable in 91.7%, 72.7%, and 75.0%, respectively. The false lumen was completely or partially thrombosed in 90.5% in zone 0, 60.0% in zone 1, and 68.2% in zone 2 at 3 years. CONCLUSIONS: The use of the Ascyrus Medical Dissection Stent in the treatment of acute DeBakey type I aortic dissection I holds promise as a simple technology that enables repair of the aortic arch and proximal descending aorta, while promoting positive aortic remodeling. Ongoing follow-up of the Dissected Aorta Repair Through Stent Implantation trial will provide long-term, prospective, clinical outcomes and radiographic data on positive remodeling of the aortic arch.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bozso SJ, Nagendran J, Chu MWA, et al. Three-year outcomes of the Dissected Aorta Repair Through Stent Implantation trial. J Thorac Cardiovasc Surg. 2022. PMID: 36220703. doi:10.1016/j.jtcvs.2022.08.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。